➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
AstraZeneca
Harvard Business School
Dow
Medtronic

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Litigation Details for Novartis Pharmaceuticals Corporation v. Shilpa Medicare Limited (D. Del. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Shilpa Medicare Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Novartis Pharmaceuticals Corporation v. Shilpa Medicare Limited (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-30 1 THE PATENTS IN SUIT 14. United States Patent No. 6,894,051 (the “’051 Patent”) duly …the ’051 Patent. 16. United States Reissue Patent No. RE43,932 (the “RE932 Patent”) duly…of the ’051 Patent and the RE932 Patent, would constitute infringement of the ’051 Patent and the RE932…date on which last-expiring patent of the ’051 Patent and the RE932 Patent expires, including any associated… This is an action for patent infringement arising under the patent laws of the United States, External link to document
0000-00-00 15 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,894,051; RE43,932. (ntl) (Entered…2015 27 July 2016 1:15-cv-01111 830 Patent None District Court, D. Delaware External link to document
2015-11-30 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,894,051; RE43,932. (nmb) (Entered…30 November 2015 1:15-cv-01111 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Moodys
Mallinckrodt
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.